EilandLS, EnglishTM, EilandEHIH. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients. Ann Pharmacother2011; 45:582–9. DOI 10.1345/aph.1P588
2.
SheinerLB, BealSL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm1981; 9:503–12.
3.
LamarreP, LebelD, DucharmeMP. A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population. Antimicrob Agents Chemother2000; 44:278–82.
4.
ZegbehH, BleyzacN, BerhouneC, BertrandY. [Vancomycin: what dosages are needed to achieve efficacy in paediatric hematology/oncology?] French. Arch Pediatr2011;18:850–5. DOI 10.1016/j.arcped.2011.05.013
5.
UaamnuichaiM, DayRB, BraterDC. Bayesian and least-squares methods for vancomycin dosing. Am J Med Sci1987; 294:100–4.
6.
TodM, JullienV, PonsG. Facilitation of drug evaluation in children by population methods and modelling. Clin Pharmacokinet2008; 47:231–43.
7.
NunnMO, CoralloCE, AubronC, PooleS, DooleyMJ, ChengAC. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software. Ann Pharmacother2011; 45:757–63. DOI 10.1345/aph.1P634
